{"id":"https://openalex.org/W3205770147","doi":"https://doi.org/10.3389/fimmu.2021.722406","title":"The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients","display_name":"The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients","publication_year":2021,"publication_date":"2021-10-11","ids":{"openalex":"https://openalex.org/W3205770147","doi":"https://doi.org/10.3389/fimmu.2021.722406","mag":"3205770147","pmid":"https://pubmed.ncbi.nlm.nih.gov/34804011","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8600565"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2021.722406","doi":"https://doi.org/10.3389/fimmu.2021.722406","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.722406","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.722406/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3205770147"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.722406/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056736569","display_name":"Huzeyfe Kulu","orcid":"https://orcid.org/0000-0002-5293-0037","observed_orcids":["https://orcid.org/0000-0002-5293-0037"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huzeyfe Kulu","raw_affiliation_strings":["Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001532091","display_name":"Mustafa Atasoy","orcid":"https://orcid.org/0000-0003-1904-9878","observed_orcids":["https://orcid.org/0000-0003-1904-9878"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mustafa Atasoy","raw_affiliation_strings":["Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058374501","display_name":"Kemal \u00d6zyurt","orcid":"https://orcid.org/0000-0002-6913-8310","observed_orcids":["https://orcid.org/0000-0002-6913-8310"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kemal \u00d6zyurt","raw_affiliation_strings":["Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091156366","display_name":"Marcus Maurer","orcid":"https://orcid.org/0000-0002-4121-481X","observed_orcids":["https://orcid.org/0000-0002-4121-481X"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Marcus Maurer","raw_affiliation_strings":["Urticaria Center of Reference and Excellence (UCARE), Dermatological Allergology, Department of Dermatology and Allergy, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urticaria Center of Reference and Excellence (UCARE), Dermatological Allergology, Department of Dermatology and Allergy, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064349835","display_name":"At\u0131l Avc\u0131","orcid":"https://orcid.org/0000-0001-5088-8923","observed_orcids":["https://orcid.org/0000-0001-5088-8923"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"At\u0131l Avc\u0131","raw_affiliation_strings":["Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042273575","display_name":"Muhammed Re\u015fat Akku\u015f","orcid":"https://orcid.org/0000-0002-7938-2173","observed_orcids":["https://orcid.org/0000-0002-7938-2173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muhammet\u00a0Re\u015fat Akku\u015f","raw_affiliation_strings":["Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043091933","display_name":"Rag\u0131p Erta\u015f","orcid":"https://orcid.org/0000-0002-9269-2619","observed_orcids":["https://orcid.org/0000-0002-9269-2619"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rag\u0131p Erta\u015f","raw_affiliation_strings":["Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urticaria Center of Reference and Excellence (UCARE), Chronic Skin Diseases Unit, Department of Dermatology, Kayseri City Hospital, Kayseri, Turkey","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5091156366"],"corresponding_institution_ids":["https://openalex.org/I7877124"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":1999,"currency":"EUR","value_usd":2155},"fwci":1.3545,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.78408912,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"12","issue":null,"first_page":"722406","last_page":"722406"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12796","display_name":"Dermatological and COVID-19 studies","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-spontaneous-urticaria","display_name":"chronic spontaneous urticaria","score":0.9490000009536743},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.9300000071525574},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.9070000052452087},{"id":"https://openalex.org/keywords/disease-control","display_name":"disease control","score":0.9879999756813049},{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":0.9110000133514404},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6980000138282776},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9539999961853027},{"id":"https://openalex.org/keywords/health-service-disruption","display_name":"healthcare disruption","score":0.4659999907016754},{"id":"https://openalex.org/keywords/gender-differences-in-treatment","display_name":"gender differences in treatment","score":0.42899999022483826}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8674225807189941},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.8674030900001526},{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.7686952352523804},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.7277362942695618},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.5540105104446411},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.5031675696372986},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.47191789746284485},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4232070744037628},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2507780194282532},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.14523202180862427},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1420626938343048},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.05642256140708923}],"mesh":[{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000080223","descriptor_name":"Chronic Urticaria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D058873","descriptor_name":"Pandemics","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.3389/fimmu.2021.722406","doi":"https://doi.org/10.3389/fimmu.2021.722406","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.722406","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.722406/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmid:34804011","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34804011","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8600565","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8600565/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:2235f84cafb444e08816173bda9b54e6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2235f84cafb444e08816173bda9b54e6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 12 (2021)","raw_type":"article"},{"id":"pmh:oai:refubium.fu-berlin.de:fub188/33645","doi":null,"is_oa":true,"landing_page_url":"https://refubium.fu-berlin.de/handle/fub188/33645","pdf_url":null,"source":{"id":"https://openalex.org/S4306402444","display_name":"Refubium (Universit\u00e4tsbibliothek der Freien Universit\u00e4t Berlin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I75951250","host_organization_name":"Freie Universit\u00e4t Berlin","host_organization_lineage":["https://openalex.org/I75951250"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"doc-type:article"},{"id":"doi:10.17169/refubium-33365","doi":"https://doi.org/10.17169/refubium-33365","is_oa":true,"landing_page_url":"https://doi.org/10.17169/refubium-33365","pdf_url":null,"source":{"id":"https://openalex.org/S7407052913","display_name":"Universit\u00e4tsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2021.722406","doi":"https://doi.org/10.3389/fimmu.2021.722406","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.722406","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.722406/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3205770147.pdf","grobid_xml":"https://content.openalex.org/works/W3205770147.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W2037982270","https://openalex.org/W2055473057","https://openalex.org/W2330047160","https://openalex.org/W2810953097","https://openalex.org/W2972157551","https://openalex.org/W2985341438","https://openalex.org/W2986728113","https://openalex.org/W3014510579","https://openalex.org/W3030939005","https://openalex.org/W3036353480","https://openalex.org/W3036377737","https://openalex.org/W3062617766","https://openalex.org/W3087862874","https://openalex.org/W3088256443","https://openalex.org/W3110738325","https://openalex.org/W3112612006","https://openalex.org/W3176789914"],"related_works":["https://openalex.org/W3204884223","https://openalex.org/W4282551469","https://openalex.org/W4205677184","https://openalex.org/W4311480247","https://openalex.org/W3110768168","https://openalex.org/W3049765888","https://openalex.org/W4385456971","https://openalex.org/W3197887662","https://openalex.org/W7118632044","https://openalex.org/W4386283772"],"abstract_inverted_index":{"Introduction:":[0],"The":[1,181,201,242],"COVID-19":[2,71,229],"pandemic":[3,29,72],"dramatically":[4],"disrupts":[5],"health":[6],"care":[7],"for":[8,50,113,244],"patients":[9,64,91,142,167,193,198,213,217],"with":[10,94,143,168,199,218],"chronic":[11,14,37],"diseases":[12],"including":[13],"spontaneous":[15],"urticaria":[16],"(CSU).":[17],"As":[18],"of":[19,27,47,183,203,233,239],"now,":[20],"it":[21],"is":[22],"unknown":[23],"if":[24,44],"the":[25,28,70,104,111,121,151,187,207,228],"effects":[26],"in":[30,35,73,115,173,178,191,196,211],"CSU":[31,48,63,95,144,153,225],"are":[32,56,67,129],"different":[33,45],"than":[34],"other":[36],"diseases.":[38],"We":[39,88],"also":[40],"do":[41],"not":[42,140,160,215,223],"know,":[43],"groups":[46],"patients,":[49,55,226],"example":[51],"female":[52,141,166,197,216,224],"and":[53,65,77,79,86,120,125,134,165,176,194],"male":[54,192,212],"affected":[57,68],"differently.":[58],"Aim:":[59],"To":[60],"understand":[61],"how":[62,126],"subgroups":[66],"by":[69],"their":[74],"disease":[75,116,118,135,148,157,174,179,234],"activity":[76,149,175],"control":[78,235],"treatment,":[80,185,205],"using":[81],"psoriasis":[82,97,169],"as":[83],"control.":[84,180],"Patients":[85],"Methods:":[87],"analyzed":[89],"399":[90],"(450":[92],"visits)":[93],"or":[96,106,156],"assessed":[98],"during":[99,110,150,186,206,227],"August":[100,107],"2019,":[101],"i.e.":[102,109],"before":[103],"pandemic,":[105,112,188,208,230],"2020,":[108],"changes":[114,128],"activity,":[117],"control,":[119],"treatment":[122],"they":[123],"used,":[124],"these":[127],"linked":[130,161,236],"to":[131,162,237,247],"age,":[132],"gender,":[133],"duration.":[136],"Results:":[137],"Male":[138,164,221],"but":[139,214,222],"had":[145],"markedly":[146],"increased":[147,195],"pandemic.":[152],"patients'":[154],"age":[155],"duration":[158],"were":[159],"changes.":[163],"showed":[170],"similar":[171],"increases":[172],"decreases":[177],"rate":[182],"omalizumab":[184,204,240],"was":[189,209],"unchanged":[190],"CSU.":[200,219],"efficacy":[202],"reduced":[210],"Conclusion:":[220],"show":[231],"loss":[232,238],"efficacy.":[241],"reasons":[243],"this":[245],"need":[246],"be":[248],"investigated.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-10-25T00:00:00"}
